Blue Trust Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$932K Sell
16,168
-3
-0% -$172 0.01% 313
2026
Q1
$981K Sell
16,171
-1,922
-11% -$112K 0.01% 294
2025
Q4
$976K Sell
18,093
-4,041
-18% -$194K 0.01% 291
2025
Q3
$998K Sell
22,134
-413
-2% -$19.3K 0.01% 298
2025
Q2
$1.04M Sell
22,547
-1,287
-5% -$63.2K 0.01% 262
2025
Q1
$1.45M Buy
23,834
+93
+0.4% +$5.42K 0.02% 196
2024
Q4
$1.34M Sell
23,741
-1,760
-7% -$98.3K 0.02% 201
2024
Q3
$1.06M Buy
25,501
+8,498
+50% +$399K 0.01% 261
2024
Q2
$922K Buy
17,003
+3,263
+24% +$146K 0.01% 229
2024
Q1
$745K Sell
13,740
-949
-6% -$48.3K 0.01% 217
2023
Q4
$852K Sell
14,689
-438
-3% -$23K 0.01% 176
2023
Q3
$968K Buy
15,127
+1,963
+15% +$120K 0.01% 172
2023
Q2
$913K Sell
13,164
-7,420
-36% -$498K 0.01% 175
2023
Q1
$1.48M Sell
20,584
-247
-1% -$17.4K 0.02% 159
2022
Q4
$1.48M Buy
20,831
+8,333
+67% +$628K 0.03% 145
2022
Q3
$962K Buy
12,498
+1,653
+15% +$120K 0.02% 148
2022
Q2
$792K Buy
+10,845
New +$826K 0.01% 157

Other funds holding BMY

Blue Trust Inc's BMY Position: Q2 2026 in Review

Blue Trust Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.02% in Q2 2026, selling an estimated $172 and leaving 16,168 shares worth $932K. The position accounts for 0.01% of the portfolio, ranked #313.

Blue Trust Inc first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.48M in Q1 2023. 938 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Blue Trust Inc held 16,168 shares of Bristol-Myers Squibb worth $932K as of Q2 2026.
  • Blue Trust Inc sold 3 Bristol-Myers Squibb shares in Q2 2026, an estimated $172.
  • Bristol-Myers Squibb made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #313 holding.
  • Blue Trust Inc first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Bristol-Myers Squibb position peaked at $1.48M in Q1 2023.
  • 938 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.